Literature DB >> 22278003

Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.

I Liepelt-Scarfone1, M Jamour, W Maetzler.   

Abstract

Co-occurrence of parkinsonism and dementia is commonly observed in the aging population. This narrative review gives an overview of disorders regularly presenting with these symptoms, e.g., idiopathic Parkinson disease with dementia, dementia with Lewy bodies, progressive supranuclear palsy, corticobasal degeneration syndrome, vascular cognitive impairment, drug-induced parkinsonism, and normal-pressure hydrocephalus. Both a thoroughly performed medical history and a comprehensive clinical examination can narrow down relevant differential diagnoses. Characteristic clinical and neuropsychological features are highlighted, including cognitive screening strategies. Neurophysiological and neuropathological aspects of the disorders are briefly discussed to give a better understanding of treatment options.

Entities:  

Mesh:

Year:  2012        PMID: 22278003     DOI: 10.1007/s00391-011-0261-7

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  44 in total

1.  Risk tables for parkinsonism and Parkinson's disease.

Authors:  Alexis Elbaz; James H Bower; Demetrius M Maraganore; Shannon K McDonnell; Brett J Peterson; J Eric Ahlskog; Daniel J Schaid; Walter A Rocca
Journal:  J Clin Epidemiol       Date:  2002-01       Impact factor: 6.437

2.  What predicts mortality in Parkinson disease?: a prospective population-based long-term study.

Authors:  E B Forsaa; J P Larsen; T Wentzel-Larsen; G Alves
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

3.  Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus.

Authors:  Andrew Tarnaris; Ahmed K Toma; Miles D Chapman; Geoff Keir; Neil D Kitchen; Laurence D Watkins
Journal:  J Neurosurg       Date:  2011-03-25       Impact factor: 5.115

4.  Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.

Authors:  Roy Hamilton; Sunil Patel; Edward B Lee; Eric M Jackson; Joanna Lopinto; Steven E Arnold; Christopher M Clark; Anuj Basil; Leslie M Shaw; Sharon X Xie; M Sean Grady; John Q Trojanowski
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

Review 5.  How to diagnose dementia with Lewy bodies: state of the art.

Authors:  Felix Geser; Gregor K Wenning; Werner Poewe; Ian McKeith
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

6.  Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study.

Authors:  Sarah T Pendlebury; Fiona C Cuthbertson; Sarah J V Welch; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2010-04-08       Impact factor: 7.914

7.  Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.

Authors:  Walter Maetzler; Velichka Stoycheva; Benjamin Schmid; Claudia Schulte; Ann-Kathrin Hauser; Kathrin Brockmann; Arthur Melms; Thomas Gasser; Daniela Berg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  Prevalence of parkinsonism and Parkinson's disease in the Arosa Island (Spain): a community-based door-to-door survey.

Authors:  M Seijo-Martinez; M Castro del Rio; J Rodríguez Alvarez; R Suarez Prado; E Torres Salgado; J Paz Esquete; M J Sobrido
Journal:  J Neurol Sci       Date:  2011-03-12       Impact factor: 3.181

Review 9.  The physics of hydrocephalus.

Authors:  Richard D Penn; Andreas Linninger
Journal:  Pediatr Neurosurg       Date:  2009-05-14       Impact factor: 1.162

10.  Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease.

Authors:  Kolbjorn Bronnick; Murat Emre; Roger Lane; Sibel Tekin; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.